T1D is characterized by inadequate endogenous insulin production [48], resulting in persistent hyperglycemia (i.e., high blood glucose/sugar levels) and necessitating lifelong exogenous insulin administration to counter this effect [51]. This evidence concerns the gene INS and Hyperglycemia.